Ignite Creation Date:
2024-05-05 @ 4:54 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00337467
Status:
COMPLETED
Last Update Posted:
2010-07-19
First Post:
2006-06-14
Brief Title:
Phase IIIb Study to Evaluate the Effectiveness and Safety of AtazanavirRitonavir as Single Enhanced Protease Inhibitor Therapy in Human Immunodeficiency Virus HIV-Infected Subjects Evidencing Virologic Suppression
Sponsor:
Bristol-Myers Squibb
Organization:
Bristol-Myers Squibb
Organization Data
Organization:
Bristol-Myers Squibb
Class:
INDUSTRY
Study ID:
AI424-227
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Bristol-Myers Squibb
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Study Director
Old Organization:
Bristol-Myers Squibb